A randomized, Open label, Cross-over Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers

Trial Profile

A randomized, Open label, Cross-over Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Dec 2017

At a glance

  • Drugs Metformin (Primary) ; Rosuvastatin (Primary)
  • Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Yuhan
  • Most Recent Events

    • 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 31 Jul 2012 Actual end date changed from Apr 2012 to May 2012 as reported by ClinicalTrials.gov.
    • 14 Mar 2012 Status changed from active, no longer recruiting to completed as reported by Korean Clinical Trials Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top